Keywords
Pertussis
Vaccinaction
Nigeria
Infant
Abstract
Background. Pertussis, also known as whooping cough, remains a significant cause of morbidity and mortality in early childhood, particularly in low- and middle-income countries (LMICs) with delayed vaccination schedules. Despite global immunization efforts, pertussis has re-emerged, presenting diagnostic and management challenges. Early recognition requires clinical acumen, as atypical presentations−especially fulminant cases−can mimic other respiratory conditions.
Case Report. This case report highlights a 9-week-old female infant with severe paroxysmal coughing and progressive respiratory distress, initially mismanaged due to delayed clinical suspicion and missed vaccination. Following appropriate antibiotic therapy and supportive measures, dramatic symptom resolution was observed. This case underscores the critical need for heightened awareness, rapid intervention, and strategic therapeutic approaches, particularly in vulnerable infant populations at risk for severe pertussis complications.
Conclusion. Persistent coughing, although a frequent clinical presentation in paediatric patients, requires an intuitive history and thorough evaluation to determine underlying etiologies. Accurate diagnosis of pertussis is essential for timely intervention, and prompt vaccination remains the most effective preventive measure.
References
Joseph JB, Bryon KM, Stephen CA. Pertussis: Practice Essentials, Background, Etiology and Pathophysiology. Medscape. Available at: https://emedicine.medscape.com/article/967268-overview February 6, 2025. Accessed on: 01/05/2025.
Muloiwa R, Wolter N, Mupere E, et al. Pertussis in Africa: Findings and recommendations of the Global Pertussis Initiative (GPI). Vaccine 2018;36:2385-93. https://doi.org/10.1016/j.vaccine.2018.03.025.
Yeside A, Omotola M. Severe infantile pertussis in Nigeria, report of two cases: the need for review of current pertussis vaccination schedule. TNHJ 2019;19. https://doi.org/10.60787/tnhj.v19i1.424.
Centers for Disease Control and Prevention. Pertussis Surveillance and Trends. Available at: https://www.cdc.gov/pertussis/php/surveillance/index.html. Accessed on: 01/05/2025.
Jia J, Yuan L, Gao W, et al. Complications of pertussis. Zhongguo Dang Dai Er Ke Za Zhi 2019;21:713-17. Chinese. https://doi.org/10.7499/j.issn.1008-8830.2019.07.018.
Lauria AM, Zabbo CP. Pertussis. StatPearls. Treasure Island (FL): StatPearls Publishing; 2025 Jan. Available at: https://www.ncbi.nlm.nih.gov/books/NBK519008/. Accessed on: 01/05/2025.
Sadoh AE, Oladokun RE. Re-emergence of diphtheria and pertussis: implications for Nigeria. Vaccine 2012;30:7221-8. https://doi.org/ https://doi.org/10.1016/j.vaccine.2012.10.014.
Nigeria Center for Disease Control and Prevention. Pertussis. Available at URL: https://ncdc.gov.ng/diseases/info/P. Accessed on: 01/05/2025.
Centers for Disease Control and Prevention. Laboratory Testing for Pertussis. Available at: https://www.cdc.gov/pertussis/php/laboratories/index.html#:~:text=Clinical%20laboratories%20can%20provide%20diagnostic,reaction%20(PCR)%20and%20serology. Accessed on: 01/05/2025.
Fiona PH, Pedro LM, Susan H, Tami S. Pertussis. Pink Book, CDC. 2021. Available at: https://www.cdc.gov/pinkbook/hcp/table-of-contents/chapter-16-pertussis.html#:~:text=Pertussis%20Pathogenesis&text=Pertussis%20is%20primarily%20a%20toxin,the%20clearing%20of%20pulmonary%20secretions. Accessed on: 01/05/2025.
WHO. Health Topics: Pertussis. Available at: https://www.who.int/health-topics/pertussis#tab=tab_2. Accessed on: 01/05/2025.